Paper39555481
Autoantibodies in neuromuscular disorders: a review of their utility in clinical practice.
Loser V and 2 others. Front Neurol, 2024. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Autoantibodies in neuromuscular disorders: a review of their utility in clinical practice. Papers, record 39555481. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39555481
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Autoantibodies in neuromuscular disorders: a review of their utility in clinical practice.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References203
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11571215 | The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies. | Brain | 2001 | https://conductscience.org/library/papers/11571215 | PubMed |
| 2 | 35259208 | Clinical, serological and genetic predictors of response to immunotherapy in anti-IgLON5 disease. | Brain | 2023 | https://conductscience.org/library/papers/35259208 | PubMed |
| 3 | 24373505 | A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis. | J Autoimmun | 2014 | https://conductscience.org/library/papers/24373505 | PubMed |
| 4 | 33093664 | Immune-mediated necrotizing myopathy: clinical features and pathogenesis. | Nat Rev Rheumatol | 2020 | https://conductscience.org/library/papers/33093664 | PubMed |
| 5 | 38522330 | 272nd ENMC international workshop: 10 Years of progress - revision of the ENMC 2013 diagnostic criteria for inclusion body myositis and clinical trial readiness. 16-18 June 2023, Hoofddorp, The Netherlands. | Neuromuscul Disord | 2024 | https://conductscience.org/library/papers/38522330 | PubMed |
| 6 | 9989618 | Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome. | Ann Neurol | 1999 | https://conductscience.org/library/papers/9989618 | PubMed |
| 7 | 6842265 | Anti-acetylcholine receptor antibodies in myasthenia gravis. Part 2. Clinical and serological follow-up of individual patients. | J Neurol Sci | 1983 | https://conductscience.org/library/papers/6842265 | PubMed |
| 8 | 32959046 | CANOMAD: a neurological monoclonal gammopathy of clinical significance that benefits from B-cell-targeted therapies. | Blood | 2020 | https://conductscience.org/library/papers/32959046 | PubMed |
| 9 | 12548526 | Sensory neuropathy with monoclonal IgM binding to a trisulfated heparin disaccharide. | Muscle Nerve | 2003 | https://conductscience.org/library/papers/12548526 | PubMed |
| 10 | 1655278 | HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal. | Cell | 1991 | https://conductscience.org/library/papers/1655278 | PubMed |
| 11 | 37272673 | Autoimmune nodo-paranodopathies 10 years later: Clinical features, pathophysiology and treatment. | J Peripher Nerv Syst | 2023 | https://conductscience.org/library/papers/37272673 | PubMed |
| 12 | 33880507 | Antibodies to the Caspr1/contactin-1 complex in chronic inflammatory demyelinating polyradiculoneuropathy. | Brain | 2021 | https://conductscience.org/library/papers/33880507 | PubMed |
| 13 | 35366559 | The clinical need for clustered AChR cell-based assay testing of seronegative MG. | J Neuroimmunol | 2022 | https://conductscience.org/library/papers/35366559 | PubMed |
| 14 | 35989569 | Autoimmune neuromyotonia. | Curr Opin Neurol | 2022 | https://conductscience.org/library/papers/35989569 | PubMed |
| 15 | 27986399 | Paranodal lesions in chronic inflammatory demyelinating polyneuropathy associated with anti-Neurofascin 155 antibodies. | Neuromuscul Disord | 2017 | https://conductscience.org/library/papers/27986399 | PubMed |
| 16 | 26789908 | P/Q- and N-type calcium-channel antibodies: Oncological, neurological, and serological accompaniments. | Muscle Nerve | 2016 | https://conductscience.org/library/papers/26789908 | PubMed |
| 17 | 37564637 | Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease. | Front Immunol | 2023 | https://conductscience.org/library/papers/37564637 | PubMed |
| 18 | 6278098 | Subacute sensory neuropathy with remission: an association with lymphoma. | J Neurol Neurosurg Psychiatry | 1982 | https://conductscience.org/library/papers/6278098 | PubMed |
| 20 | 1514781 | Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. | Ann Neurol | 1992 | https://conductscience.org/library/papers/1514781 | PubMed |
| 21 | 25969757 | Ganglioside biochemistry. | ISRN Biochem | 2012 | https://conductscience.org/library/papers/25969757 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42747330 | Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach From the Writing Committee of the American Society for Apheresis: The Tenth Special Issue. | J Clin Apher | 2026 | https://conductscience.org/library/papers/42747330 | PubMed |
| 41762439 | Myopathies in clinical care: a focus on treatable causes. | J Neural Transm (Vienna) | 2026 | https://conductscience.org/library/papers/41762439 | PubMed |
| 41050276 | Comparison of the presentation and electrophysiological characteristics of autoimmune nodopathies in patients with antibody-negative CIDP and CMT1. | Front Neurol | 2025 | https://conductscience.org/library/papers/41050276 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39555481
GET https://conductscience.org/api/papers/v1/39555481/references?page=2